Validity and reliability of State-Trait Anxiety Inventory in Danish women aged 45 years and older with abnormal cervical screening results

Gustafson, Line Winther; Gabel, Pernille; Hammer, Anne; Lauridsen, Henrik Hein; Petersen, Lone Kjeld; Andersen, Berit; Bor, Pınar; Larsen, Mette Bach

doi:10.1186/s12874-020-00982-4

Cited by 42 publications

(41 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We assessed the state anxiety in the present study. All items were rated on a 4-point scale (e.g., from "almost never" to "almost always") [12,13]. Higher scores indicate greater anxiety.…”

Section: Section III the State-trait Anxiety Inventory (Stai)mentioning

confidence: 99%

Assessment of Anxiety, Depression, Attitude, and Coping Strategies of the Egyptian Population during the COVID-19 Pandemic

Shehata

Gabra

Eltellawy

et al. 2021

JCM

View full text Add to dashboard Cite

Background: The COVID-19 pandemic has imposed several challenges on different populations all around the world, with stress being identified as one of the major challenges. This study aims to investigate the impact of COVID-19-induced stress on the prevalence and severity of anxiety and/or depression, factors that predict the development of anxiety and/or depression, and coping strategies in the Egyptian population during the COVID 19 outbreak. Subjects and Methods: This is an observational cross-sectional online study. The questionnaire of our study included five sections: demographic and clinical data, attitude towards COVID-19, the State-Trait Anxiety Inventory (STAI), Beck Depression Inventory-II (BDI-II), and a specifically prepared and standardized Arabic version of a coping strategies scale. The questionnaire was uploaded on 20 May 2020 at 1 p.m. and closed on 7 July 2020 at 8 a.m. Results: The study questionnaire was completed by 283 Egyptians, with mean age 34.81 ± 11.36 years, of which 17% had been infected with COVID-19. The responses showed that 62.9% had moderate anxiety, whereas 12.4% had severe anxiety. Moreover, 13.8% had moderate depression, and 14.1% had severe depression. Our study demonstrated that age, mental status, and being infected with COVID-19 correlated with depression, whereas only age correlated with anxiety. Interestingly, our data showed that anxiety and depression were negatively correlated with some coping strategies during the COVID-19 pandemic. Conclusions: Pandemics, such as the COVID-19 pandemic, imposes stress on individuals, which leads to the development of anxiety and/or depression. Several factors, which could be population-dependent, may help predict the development of anxiety or depression. We show the factors correlated with depression and anxiety during the COVID-19 pandemic in the Egyptian population. Furthermore, certain personal coping strategies during the COVID-19 pandemic are negatively correlated with anxiety and depression. Therefore, our study sheds light on the importance of studying factors in each population that can lead to pandemic-induced psychological complications and those that can relieve such complications.

show abstract

“…We assessed the state anxiety in the present study. All items were rated on a 4-point scale (e.g., from "almost never" to "almost always") [12,13]. Higher scores indicate greater anxiety.…”

Section: Section III the State-trait Anxiety Inventory (Stai)mentioning

confidence: 99%

Assessment of Anxiety, Depression, Attitude, and Coping Strategies of the Egyptian Population during the COVID-19 Pandemic

Shehata

Gabra

Eltellawy

et al. 2021

JCM

View full text Add to dashboard Cite

show abstract

“…This value is comparable to Cronbach's alpha STAI-S value in scientific literature. [28][29][30] The high reliability of measurements using the STAI-S questionnaires in the study allows these tools to be used as a reference for NRS-A validation. The other standardized anxiety measuring tools (STAI-T and HADS-A) were also highly reliable.…”

Section: Discussionmentioning

confidence: 99%

Validation of the Numerical Anxiety Rating Scale in postpartum females: a prospective observational study

2022

View full text Add to dashboard Cite

show abstract

“…The STAI‐T identified trait anxiety levels. It has high internal consistency (α = 0.86–0.95) [47] and good test–retest reliability ( r = 0.80) [50].…”

Section: Methodsmentioning

confidence: 99%

The impact of depressed mood and coping motives on cannabis use quantity across the menstrual cycle in those with and without pre‐menstrual dysphoric disorder

et al. 2021

View full text Add to dashboard Cite

Background and Aims Reported rates of cannabis use among Canadian females are increasing. Female cannabis users progress to cannabis use disorder more rapidly than males (telescoping) and have higher rates of emotional disorder comorbidity. Addictive behaviors may change, along with mood and motivations, across the menstrual cycle (MC), particularly for females with pre‐menstrual dysphoric disorder (PMDD). This study aimed to determine whether increases in depressed mood and coping motives would predict increased cannabis use pre‐menstrually/menstrually, particularly among females with PMDD. We also assessed positive mood and enhancement motive ratings to establish specificity of predicted depressed mood and coping motive results. Design Observational study using data collected across 32 days using electronic daily diary methods. Setting Nova Scotia, Canada. Participants Sixty‐nine naturally cycling female cannabis users (Mean (M) age = 29.25, Standard Deviation (SD) = 5.66) with and without retrospectively identified PMDD (via structured clinical interview) and prospectively identified PMDD (via elevated pre‐menstrual depressed mood). Self‐reported MC phase was validated using salivary progesterone concentrations. Measurements Depressed/positive mood, coping‐/enhancement‐motivated cannabis use, and cannabis use quantity. Findings Coping motives explained heightened cannabis use pre‐menstrually/menstrually in those with retrospectively identified PMDD. Depressed mood explained increased cannabis use menstrually in those with retrospectively/prospectively identified PMDD. Moreover, prospectively identified PMDD significantly moderated the relationship between depressed mood and cannabis use quantity menstrually. In those with prospectively identified PMDD, positive mood and enhancement motives were associated with decreased cannabis use during the follicular/ovulatory phases. Females with versus without retrospectively identified PMDD also displayed greater overall cannabis use quantity (M [SD] = 3.44[2.84] standard joint equivalents versus 1.85[1.82], respectively; U = 277.50, P = 0.008). Conclusions Depressed mood may explain heightened cannabis use menstrually in females with pre‐menstrual dysphoric disorder. Coping motives may explain heightened cannabis use pre‐menstrually/menstrually in females with retrospectively identified with pre‐menstrual dysphoric disorder.

show abstract

Validity and reliability of State-Trait Anxiety Inventory in Danish women aged 45 years and older with abnormal cervical screening results

Cited by 42 publications

References 22 publications

Assessment of Anxiety, Depression, Attitude, and Coping Strategies of the Egyptian Population during the COVID-19 Pandemic

Assessment of Anxiety, Depression, Attitude, and Coping Strategies of the Egyptian Population during the COVID-19 Pandemic

Validation of the Numerical Anxiety Rating Scale in postpartum females: a prospective observational study

The impact of depressed mood and coping motives on cannabis use quantity across the menstrual cycle in those with and without pre‐menstrual dysphoric disorder

Contact Info

Product

Resources

About